ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Leukemia
Acute Myeloid Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Cancer

Acute Myeloid Leukemia (AML) trials near Austin, TX, USA:

Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Acute myeloid leukemia (AML) is the second most common type of leukemia diagnosed in adults and children ...

Enrolling
Acute Myeloid Leukemia
Drug: ABBV-787

Phase 1

AbbVie
AbbVie

Austin, Texas, United States and 23 other locations

The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) and/or recommended dose (RD) of SG...

Enrolling
Acute Myeloid Leukemia
High-Risk and Very High-Risk Myelodysplastic Syndromes
Drug: SGR-2921

Phase 1

Schrödinger, Inc.

Austin, Texas, United States and 11 other locations

(mCRPC), higher risk myelodysplastic syndrome (HRMDS), acute myeloid leukemia (AML) and newly diagnosed intermed...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Drug: ASTX727
Drug: KPT-8602

Phase 1, Phase 2

Karyopharm Therapeutics
Karyopharm Therapeutics

Austin, Texas, United States and 45 other locations

This study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart...

Active, not recruiting
Chronic Lymphocytic Leukemia
Acute Myeloid Leukemia
Drug: Docetaxel
Drug: Aplitabart (IGM-8444)

Phase 1

IGM Biosciences
IGM Biosciences

Austin, Texas, United States and 57 other locations

combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...

Enrolling
Leukemia
Drug: Quizartinib
Drug: Placebo

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Austin, Texas, United States and 251 other locations

This Phase 1 study will assess the safety, tolerability, and preliminary antileukemic activity of ziftomenib in combination with venetoclax and azaci...

Enrolling
Myeloid Sarcoma
Mixed Phenotype Acute Leukemia
Drug: Daunorubicin
Drug: Cytarabine

Phase 1

Kura Oncology

Austin, Texas, United States and 27 other locations

Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk of death ...

Active, not recruiting
Myelodysplastic Syndrome (MDS)
Drug: Placebo
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Austin, Texas, United States and 221 other locations

with bone marrow from a deceased donor in patients with acute leukemias. Patients will either receive myeloablative conditioning or...

Enrolling
Acute Biphenotypic Leukemia
Acute Leukemia
Other: Ossium HPC Marrow, Bone Marrow Transplant
Other: Pre-transplant conditioning - Myeloablative (MAC)

Phase 1, Phase 2

Ossium Health

Austin, Texas, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems